Greenness assessment of micellar spectrofluorometric approach for determination of Elagolix: application to dosage form, content uniformity and human plasma
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
Ecological, sensitive, fast and economic approaches are the main aspects in quality control of pharmaceutical products. Elagolix (ELG) is an orally non-peptidic GnRH antagonist, recently approved drug by Food and drug administration in 2018 for treatment of pain associated with endometriosis. A green, and sensitive method was developed and validated for determination of ELG based on micellar spectrofluorometric approach. Many factors were studied to enhance the fluorescence intensity of ELG and the highest sensitivity was obtained upon using 1% Sodium dodecyl sulphate (SDS) at 438 nm after excitation at 270 nm. A linear relationship was obtained over a range of 50–1000 ng mL−1 between ELG concentration and corresponding fluorescence intensity. The developed method was validated according to ICH guidelines and successfully applied for testing the content uniformity and determination of ELG in pharmaceutical dosage forms with percentage recovery 99.31 ± 1.98. Furthermore, the capability of the method due to its high sensitivity to determine ELG in human plasma with percentage recoveries in a range of 98.54–100.46. The greenness of the method was investigated using three different approaches; Analytical Procedure Index (GAPI), Analytical Eco-Scale and Analytical Greenness Metric (AGREE).
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Analytical methodology and pharmacokinetic study of elagolix in plasma of rats using a newly developed UPLC-MS/MS assay via openalex
- Elagolix for endometriosis: all that glitters is not gold via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Épidémiologie de l’endométriose via openalex
- Is acupuncture effective in the treatment of pain in endometriosis? via openalex
- Population Pharmacokinetics of Elagolix in Healthy Women and Women with Endometriosis via openalex
- Systematic review and meta‐analysis of complementary treatments for women with symptomatic endometriosis via openalex
- The Clinical Anatomy of Endometriosis: A Review via openalex
- W6634813756 via openalex
- W1579613180 via openalex
- W6755275375 via openalex
- W1996842820 via openalex
- W2002033062 via openalex
- W2781931056 via openalex
- W2903008496 via openalex
- W2990363083 via openalex
- W2998848150 via openalex
- W3035028232 via openalex
- W3180072649 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-14T06:08:20.186862+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00
License: CC0
· commercial use OK